Imanol Arozarena
- Molecular Biology top 5%
- Oncology top 5%
- Cell Biology top 2%
- Immunology top 5%
- Cancer Research top 10%
- Co-authors
- Claudia WellbrockPiero CrespoRichard MaraisDavid MatallanasMarı́a T. BercianoFernando CalvoVictoria Sanz‐MorenoRobert Hayward
- Topics
- Melanoma and MAPK Pathways (15 papers)Protein Kinase Regulation and GTPase Signaling (9 papers)Cutaneous Melanoma Detection and Management (7 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Imanol Arozarena
36 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 1.6k
- Oncology 843
- Cell Biology 484
- Immunology 468
- Cancer Research 257
Countries citing papers authored by Imanol Arozarena
This map shows the geographic impact of Imanol Arozarena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imanol Arozarena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imanol Arozarena more than expected).
Fields of papers citing papers by Imanol Arozarena
This network shows the impact of papers produced by Imanol Arozarena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imanol Arozarena. The network helps show where Imanol Arozarena may publish in the future.
Co-authorship network of co-authors of Imanol Arozarena
This figure shows the co-authorship network connecting the top 25 collaborators of Imanol Arozarena. A scholar is included among the top collaborators of Imanol Arozarena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imanol Arozarena. Imanol Arozarena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 11 | |
| 3 | 17 | |
| 4 | 223 | |
| 5 | 94 | |
| 6 | 88 | |
| 7 | 33 | |
| 8 | 151 | |
| 9 | 4 | |
| 10 | 82 | |
| 11 | 55 | |
| 12 | 168 | |
| 13 | 98 | |
| 14 | FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKC epsilon, B-Raf and S6K2 | 9 |
| 15 | 144 | |
| 16 | 107 | |
| 17 | 83 | |
| 18 | 100 | |
| 19 | 25 | |
| 20 | 51 |
About Imanol Arozarena
Imanol Arozarena is a scholar working on Immunology and Allergy, Cell Biology and Oncology, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (15 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). The work is most often cited by research in Oncology (843 citations), Cell Biology (484 citations) and Molecular Biology (1.6k citations). Imanol Arozarena has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Claudia Wellbrock, Piero Crespo, Richard Marais, David Matallanas, Marı́a T. Berciano, Fernando Calvo, Victoria Sanz‐Moreno, Robert Hayward, Michael P. Smith and Miguel Lafarga. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.